A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

May 31, 2023

Conditions
Multiple Myeloma
Interventions
DRUG

Ixazomib

Ixazomib capsules.

DRUG

Thalidomide

Thalidomide capsules.

DRUG

Dexamethasone

Dexamethasone tablets.

Trial Locations (6)

40110-090

CEHON Centro de Hematologia e Oncologia da Bahia, Salvador

22793-080

Instituto COI de Educacao e Pesquisa, Rio de Janeiro

90035-003

Hospital de Clinicas de Porto Alegre, Porto Alegre

13083-878

Universidade Estadual de Campinas UNICAMP - HEMOCENTRO, Campinas

04537-080

Clinica Medica Sao Germano S/S Ltda., São Paulo

05403-010

Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY